FAKTOR OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000GX6HTC2

Market Closed - BOERSE MUENCHEN 11:56:53 24/05/2024 pm IST
0.646 EUR +7.49% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-17.39%
1 month-19.45%
Date Price Change
24/24/24 0.646 +7.49%
23/24/23 0.601 -5.65%
22/24/22 0.637 +10.59%
21/24/21 0.576 -2.21%
20/24/20 0.589 -4.54%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 11:56 pm IST

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GX6HTC
ISINDE000GX6HTC2
Date issued 21/12/2021
Strike 287.5 $
Maturity Unlimited
Parity 76.47 : 1
Emission price 10.03
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 21.39
Lowest since issue 0.216
Spread 0.01
Spread %1.54%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.5 USD
Average target price
372.4 USD
Spread / Average Target
+10.97%
Consensus